Aim & Scope
Annals of Infectious Diseases and Therapy (AIDT) is an international, peer-reviewed, open-access journal published by Somato Publications. The journal was established in 2020 and publishes work that advances knowledge and practice in infectious diseases and therapy.
Aims
- To provide a rigorous, transparent, and rapid venue for original research in infectious diseases and therapy.
- To make research freely and permanently available to readers everywhere, without subscription or access barriers.
- To connect researchers, practitioners, and policy makers across disciplines and regions.
- To uphold the highest standards of research integrity and publication ethics.
Scope
The journal welcomes submissions on all aspects of infectious diseases and therapy, including but not limited to:
- Bacterial, viral, fungal, and parasitic infections
- Clinical microbiology, diagnostics, and laboratory methods
- Antimicrobial therapy, pharmacology, and stewardship
- Antimicrobial resistance: mechanisms, surveillance, and control
- HIV/AIDS, tuberculosis, malaria, and viral hepatitis
- Emerging and re-emerging infections, and pandemic preparedness
- Healthcare-associated infections and infection prevention and control
- Vaccines, immunisation, and host immune response to infection
- Tropical, travel, and neglected tropical diseases
- Infections in immunocompromised, paediatric, and elderly patients
- Epidemiology, outbreak investigation, and public health response
- Novel therapeutics, including antivirals, biologics, and phage therapy
Manuscripts outside this scope, or that make no original contribution, may be declined without external review.
Article types
| Type | Description | Word limit* |
|---|---|---|
| Original Research | Full reports of hypothesis-driven or descriptive studies | 5,000 |
| Review Article | Systematic, scoping, or narrative reviews | 7,000 |
| Short Communication | Brief reports of preliminary or focused findings | 2,500 |
| Case Report / Case Series | Clinically or programmatically instructive cases | 2,000 |
| Policy Analysis / Perspective | Evidence-based commentary on policy or practice | 3,000 |
| Letter to the Editor | Response to a published article | 800 |
| Editorial | Commissioned by the Editor-in-Chief | 1,500 |
* Excluding abstract, references, tables, and figure legends.
Audience
Infectious disease physicians, clinical microbiologists, infection prevention and control practitioners, pharmacists, epidemiologists, public health professionals, researchers, and students in infectious diseases and allied biomedical disciplines.
Frequency
Continuous publication. Accepted articles are published online as soon as they are ready and assigned to the current volume.
Last updated: 29 September 2026
